https://compoundevidence.com/monographs/semaglutide/2024-08-16 https://compoundevidence.com/monographs/semaglutide/pharmacology/2024-08-16 https://compoundevidence.com/monographs/semaglutide/clinical-evidence/2024-08-16 https://compoundevidence.com/monographs/semaglutide/safety/2024-08-16 https://compoundevidence.com/monographs/semaglutide/regulatory/2024-08-16 https://compoundevidence.com/monographs/semaglutide/analytical/2024-08-16 https://compoundevidence.com/monographs/semaglutide/supply/2024-08-16 https://compoundevidence.com/monographs/semaglutide/references/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/obesity/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/t2dm/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/cvd/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/ckd/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/hfpef/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/mash/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/adolescent-obesity/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/prediabetes/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/pad/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/hypertension/2024-08-16 https://compoundevidence.com/monographs/semaglutide/evidence/sarcopenia/2024-08-16 https://compoundevidence.com/monographs/oral-semaglutide/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/pharmacology/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/clinical-evidence/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/safety/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/regulatory/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/analytical/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/supply/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/references/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/evidence/t2dm/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/evidence/cvd/2024-06-28 https://compoundevidence.com/monographs/oral-semaglutide/evidence/obesity/2024-06-28 https://compoundevidence.com/monographs/tirzepatide/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/pharmacology/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/clinical-evidence/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/safety/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/regulatory/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/analytical/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/supply/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/references/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/obesity/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/t2dm/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/osa/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/hfpef/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/cvd/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/mash/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/prediabetes/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/sarcopenia/2025-01-16 https://compoundevidence.com/monographs/tirzepatide/evidence/knee-oa/2025-01-16 https://compoundevidence.com/monographs/retatrutide/2023-05-19 https://compoundevidence.com/monographs/retatrutide/pharmacology/2023-05-19 https://compoundevidence.com/monographs/retatrutide/clinical-evidence/2023-05-19 https://compoundevidence.com/monographs/retatrutide/safety/2023-05-19 https://compoundevidence.com/monographs/retatrutide/regulatory/2023-05-19 https://compoundevidence.com/monographs/retatrutide/analytical/2023-05-19 https://compoundevidence.com/monographs/retatrutide/supply/2023-05-19 https://compoundevidence.com/monographs/retatrutide/references/2023-05-19 https://compoundevidence.com/monographs/retatrutide/evidence/obesity/2023-05-19 https://compoundevidence.com/monographs/retatrutide/evidence/t2dm/2023-05-19 https://compoundevidence.com/monographs/retatrutide/evidence/mash/2023-05-19 https://compoundevidence.com/monographs/retatrutide/evidence/osa/2023-05-19 https://compoundevidence.com/monographs/cagrilintide/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/pharmacology/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/clinical-evidence/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/safety/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/regulatory/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/analytical/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/supply/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/references/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/evidence/obesity/2025-02-06 https://compoundevidence.com/monographs/cagrilintide/evidence/t2dm/2025-02-06 https://compoundevidence.com/monographs/cagrisema/2025-02-24 https://compoundevidence.com/monographs/cagrisema/pharmacology/2025-02-24 https://compoundevidence.com/monographs/cagrisema/clinical-evidence/2025-02-24 https://compoundevidence.com/monographs/cagrisema/safety/2025-02-24 https://compoundevidence.com/monographs/cagrisema/regulatory/2025-02-24 https://compoundevidence.com/monographs/cagrisema/analytical/2025-02-24 https://compoundevidence.com/monographs/cagrisema/supply/2025-02-24 https://compoundevidence.com/monographs/cagrisema/references/2025-02-24 https://compoundevidence.com/monographs/cagrisema/evidence/obesity/2025-02-24 https://compoundevidence.com/monographs/cagrisema/evidence/t2dm/2025-02-24 https://compoundevidence.com/monographs/liraglutide/2024-08-27 https://compoundevidence.com/monographs/liraglutide/pharmacology/2024-08-27 https://compoundevidence.com/monographs/liraglutide/clinical-evidence/2024-08-27 https://compoundevidence.com/monographs/liraglutide/safety/2024-08-27 https://compoundevidence.com/monographs/liraglutide/regulatory/2024-08-27 https://compoundevidence.com/monographs/liraglutide/analytical/2024-08-27 https://compoundevidence.com/monographs/liraglutide/supply/2024-08-27 https://compoundevidence.com/monographs/liraglutide/references/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/obesity/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/t2dm/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/cvd/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/prediabetes/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/adolescent-obesity/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/osa/2024-08-27 https://compoundevidence.com/monographs/liraglutide/evidence/t1dm-adjunct/2024-08-27 https://compoundevidence.com/monographs/dulaglutide/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/pharmacology/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/clinical-evidence/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/safety/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/regulatory/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/analytical/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/supply/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/references/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/evidence/t2dm/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/evidence/cvd/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/evidence/obesity/2025-09-23 https://compoundevidence.com/monographs/dulaglutide/evidence/ckd/2025-09-23 https://compoundevidence.com/monographs/exenatide/2026-04-17 https://compoundevidence.com/monographs/exenatide/pharmacology/2026-04-17 https://compoundevidence.com/monographs/exenatide/clinical-evidence/2026-04-17 https://compoundevidence.com/monographs/exenatide/safety/2026-04-17 https://compoundevidence.com/monographs/exenatide/regulatory/2026-04-17 https://compoundevidence.com/monographs/exenatide/analytical/2026-04-17 https://compoundevidence.com/monographs/exenatide/supply/2026-04-17 https://compoundevidence.com/monographs/exenatide/references/2026-04-17 https://compoundevidence.com/monographs/exenatide/evidence/t2dm/2026-04-17 https://compoundevidence.com/monographs/exenatide/evidence/cvd/2026-04-17 https://compoundevidence.com/monographs/exenatide/evidence/obesity/2026-04-17 https://compoundevidence.com/monographs/exenatide/evidence/gastroparesis/2026-04-17 https://compoundevidence.com/monographs/lixisenatide/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/pharmacology/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/clinical-evidence/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/safety/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/regulatory/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/analytical/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/supply/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/references/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/evidence/t2dm/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/evidence/cvd/2025-04-12 https://compoundevidence.com/monographs/lixisenatide/evidence/obesity/2025-04-12 https://compoundevidence.com/monographs/orforglipron/2026-04-30 https://compoundevidence.com/monographs/orforglipron/pharmacology/2026-04-30 https://compoundevidence.com/monographs/orforglipron/clinical-evidence/2026-04-30 https://compoundevidence.com/monographs/orforglipron/safety/2026-04-30 https://compoundevidence.com/monographs/orforglipron/regulatory/2026-04-30 https://compoundevidence.com/monographs/orforglipron/analytical/2026-04-30 https://compoundevidence.com/monographs/orforglipron/supply/2026-04-30 https://compoundevidence.com/monographs/orforglipron/references/2026-04-30 https://compoundevidence.com/monographs/orforglipron/evidence/obesity/2026-04-30 https://compoundevidence.com/monographs/orforglipron/evidence/t2dm/2026-04-30 https://compoundevidence.com/monographs/danuglipron/2026-07-20 https://compoundevidence.com/monographs/danuglipron/pharmacology/2026-07-20 https://compoundevidence.com/monographs/danuglipron/clinical-evidence/2026-07-20 https://compoundevidence.com/monographs/danuglipron/safety/2026-07-20 https://compoundevidence.com/monographs/danuglipron/regulatory/2026-07-20 https://compoundevidence.com/monographs/danuglipron/analytical/2026-07-20 https://compoundevidence.com/monographs/danuglipron/supply/2026-07-20 https://compoundevidence.com/monographs/danuglipron/references/2026-07-20 https://compoundevidence.com/monographs/danuglipron/evidence/t2dm/2026-07-20 https://compoundevidence.com/monographs/danuglipron/evidence/obesity/2026-07-20 https://compoundevidence.com/monographs/survodutide/2025-11-19 https://compoundevidence.com/monographs/survodutide/pharmacology/2025-11-19 https://compoundevidence.com/monographs/survodutide/clinical-evidence/2025-11-19 https://compoundevidence.com/monographs/survodutide/safety/2025-11-19 https://compoundevidence.com/monographs/survodutide/regulatory/2025-11-19 https://compoundevidence.com/monographs/survodutide/analytical/2025-11-19 https://compoundevidence.com/monographs/survodutide/supply/2025-11-19 https://compoundevidence.com/monographs/survodutide/references/2025-11-19 https://compoundevidence.com/monographs/survodutide/evidence/obesity/2025-11-19 https://compoundevidence.com/monographs/survodutide/evidence/mash/2025-11-19 https://compoundevidence.com/monographs/survodutide/evidence/t2dm/2025-11-19 https://compoundevidence.com/monographs/mazdutide/2026-06-22 https://compoundevidence.com/monographs/mazdutide/pharmacology/2026-06-22 https://compoundevidence.com/monographs/mazdutide/clinical-evidence/2026-06-22 https://compoundevidence.com/monographs/mazdutide/safety/2026-06-22 https://compoundevidence.com/monographs/mazdutide/regulatory/2026-06-22 https://compoundevidence.com/monographs/mazdutide/analytical/2026-06-22 https://compoundevidence.com/monographs/mazdutide/supply/2026-06-22 https://compoundevidence.com/monographs/mazdutide/references/2026-06-22 https://compoundevidence.com/monographs/mazdutide/evidence/obesity/2026-06-22 https://compoundevidence.com/monographs/mazdutide/evidence/t2dm/2026-06-22 https://compoundevidence.com/monographs/ecnoglutide/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/pharmacology/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/clinical-evidence/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/safety/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/regulatory/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/analytical/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/supply/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/references/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/evidence/obesity/2025-06-27 https://compoundevidence.com/monographs/ecnoglutide/evidence/t2dm/2025-06-27 https://compoundevidence.com/monographs/petrelintide/2025-04-20 https://compoundevidence.com/monographs/petrelintide/pharmacology/2025-04-20 https://compoundevidence.com/monographs/petrelintide/clinical-evidence/2025-04-20 https://compoundevidence.com/monographs/petrelintide/safety/2025-04-20 https://compoundevidence.com/monographs/petrelintide/regulatory/2025-04-20 https://compoundevidence.com/monographs/petrelintide/analytical/2025-04-20 https://compoundevidence.com/monographs/petrelintide/supply/2025-04-20 https://compoundevidence.com/monographs/petrelintide/references/2025-04-20 https://compoundevidence.com/monographs/petrelintide/evidence/obesity/2025-04-20 https://compoundevidence.com/monographs/amycretin/2024-08-11 https://compoundevidence.com/monographs/amycretin/pharmacology/2024-08-11 https://compoundevidence.com/monographs/amycretin/clinical-evidence/2024-08-11 https://compoundevidence.com/monographs/amycretin/safety/2024-08-11 https://compoundevidence.com/monographs/amycretin/regulatory/2024-08-11 https://compoundevidence.com/monographs/amycretin/analytical/2024-08-11 https://compoundevidence.com/monographs/amycretin/supply/2024-08-11 https://compoundevidence.com/monographs/amycretin/references/2024-08-11 https://compoundevidence.com/monographs/amycretin/evidence/obesity/2024-08-11 https://compoundevidence.com/monographs/maridebart-cafraglutide/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/pharmacology/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/clinical-evidence/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/safety/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/regulatory/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/analytical/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/supply/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/references/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/evidence/obesity/2025-05-19 https://compoundevidence.com/monographs/maridebart-cafraglutide/evidence/t2dm/2025-05-19 https://compoundevidence.com/monographs/pramlintide/2026-07-15 https://compoundevidence.com/monographs/pramlintide/pharmacology/2026-07-15 https://compoundevidence.com/monographs/pramlintide/clinical-evidence/2026-07-15 https://compoundevidence.com/monographs/pramlintide/safety/2026-07-15 https://compoundevidence.com/monographs/pramlintide/regulatory/2026-07-15 https://compoundevidence.com/monographs/pramlintide/analytical/2026-07-15 https://compoundevidence.com/monographs/pramlintide/supply/2026-07-15 https://compoundevidence.com/monographs/pramlintide/references/2026-07-15 https://compoundevidence.com/monographs/pramlintide/evidence/t1dm-adjunct/2026-07-15 https://compoundevidence.com/monographs/pramlintide/evidence/t2dm/2026-07-15 https://compoundevidence.com/monographs/pramlintide/evidence/obesity/2026-07-15 https://compoundevidence.com/monographs/teduglutide/2024-01-30 https://compoundevidence.com/monographs/teduglutide/pharmacology/2024-01-30 https://compoundevidence.com/monographs/teduglutide/clinical-evidence/2024-01-30 https://compoundevidence.com/monographs/teduglutide/safety/2024-01-30 https://compoundevidence.com/monographs/teduglutide/regulatory/2024-01-30 https://compoundevidence.com/monographs/teduglutide/analytical/2024-01-30 https://compoundevidence.com/monographs/teduglutide/supply/2024-01-30 https://compoundevidence.com/monographs/teduglutide/references/2024-01-30 https://compoundevidence.com/monographs/teduglutide/evidence/ibd/2024-01-30 https://compoundevidence.com/monographs/tesamorelin/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/pharmacology/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/clinical-evidence/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/safety/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/regulatory/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/analytical/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/supply/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/references/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/evidence/lipodystrophy/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/evidence/mash/2024-09-01 https://compoundevidence.com/monographs/tesamorelin/evidence/ghd/2024-09-01 https://compoundevidence.com/monographs/sermorelin/2026-06-15 https://compoundevidence.com/monographs/sermorelin/pharmacology/2026-06-15 https://compoundevidence.com/monographs/sermorelin/clinical-evidence/2026-06-15 https://compoundevidence.com/monographs/sermorelin/safety/2026-06-15 https://compoundevidence.com/monographs/sermorelin/regulatory/2026-06-15 https://compoundevidence.com/monographs/sermorelin/analytical/2026-06-15 https://compoundevidence.com/monographs/sermorelin/supply/2026-06-15 https://compoundevidence.com/monographs/sermorelin/references/2026-06-15 https://compoundevidence.com/monographs/sermorelin/evidence/ghd/2026-06-15 https://compoundevidence.com/monographs/sermorelin/evidence/longevity/2026-06-15 https://compoundevidence.com/monographs/cjc-1295/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/pharmacology/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/clinical-evidence/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/safety/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/regulatory/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/analytical/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/supply/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/references/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/evidence/ghd/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/evidence/longevity/2024-07-14 https://compoundevidence.com/monographs/cjc-1295/evidence/sarcopenia/2024-07-14 https://compoundevidence.com/monographs/ipamorelin/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/pharmacology/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/clinical-evidence/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/safety/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/regulatory/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/analytical/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/supply/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/references/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/evidence/ghd/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/evidence/gastroparesis/2026-02-20 https://compoundevidence.com/monographs/ipamorelin/evidence/sarcopenia/2026-02-20 https://compoundevidence.com/monographs/hexarelin/2024-03-10 https://compoundevidence.com/monographs/hexarelin/pharmacology/2024-03-10 https://compoundevidence.com/monographs/hexarelin/clinical-evidence/2024-03-10 https://compoundevidence.com/monographs/hexarelin/safety/2024-03-10 https://compoundevidence.com/monographs/hexarelin/regulatory/2024-03-10 https://compoundevidence.com/monographs/hexarelin/analytical/2024-03-10 https://compoundevidence.com/monographs/hexarelin/supply/2024-03-10 https://compoundevidence.com/monographs/hexarelin/references/2024-03-10 https://compoundevidence.com/monographs/hexarelin/evidence/ghd/2024-03-10 https://compoundevidence.com/monographs/hexarelin/evidence/cvd/2024-03-10 https://compoundevidence.com/monographs/ghrp-2/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/pharmacology/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/clinical-evidence/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/safety/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/regulatory/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/analytical/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/supply/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/references/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/evidence/ghd/2024-04-17 https://compoundevidence.com/monographs/ghrp-2/evidence/sarcopenia/2024-04-17 https://compoundevidence.com/monographs/ghrp-6/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/pharmacology/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/clinical-evidence/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/safety/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/regulatory/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/analytical/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/supply/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/references/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/evidence/ghd/2025-09-21 https://compoundevidence.com/monographs/ghrp-6/evidence/wound-healing/2025-09-21 https://compoundevidence.com/monographs/aod-9604/2025-09-17 https://compoundevidence.com/monographs/aod-9604/pharmacology/2025-09-17 https://compoundevidence.com/monographs/aod-9604/clinical-evidence/2025-09-17 https://compoundevidence.com/monographs/aod-9604/safety/2025-09-17 https://compoundevidence.com/monographs/aod-9604/regulatory/2025-09-17 https://compoundevidence.com/monographs/aod-9604/analytical/2025-09-17 https://compoundevidence.com/monographs/aod-9604/supply/2025-09-17 https://compoundevidence.com/monographs/aod-9604/references/2025-09-17 https://compoundevidence.com/monographs/aod-9604/evidence/obesity/2025-09-17 https://compoundevidence.com/monographs/aod-9604/evidence/knee-oa/2025-09-17 https://compoundevidence.com/monographs/igf-1-lr3/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/pharmacology/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/clinical-evidence/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/safety/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/regulatory/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/analytical/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/supply/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/references/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/evidence/sarcopenia/2024-06-18 https://compoundevidence.com/monographs/igf-1-lr3/evidence/ghd/2024-06-18 https://compoundevidence.com/monographs/bpc-157/2024-05-11 https://compoundevidence.com/monographs/bpc-157/pharmacology/2024-05-11 https://compoundevidence.com/monographs/bpc-157/clinical-evidence/2024-05-11 https://compoundevidence.com/monographs/bpc-157/safety/2024-05-11 https://compoundevidence.com/monographs/bpc-157/regulatory/2024-05-11 https://compoundevidence.com/monographs/bpc-157/analytical/2024-05-11 https://compoundevidence.com/monographs/bpc-157/supply/2024-05-11 https://compoundevidence.com/monographs/bpc-157/references/2024-05-11 https://compoundevidence.com/monographs/bpc-157/evidence/ibd/2024-05-11 https://compoundevidence.com/monographs/bpc-157/evidence/tendon-injury/2024-05-11 https://compoundevidence.com/monographs/bpc-157/evidence/wound-healing/2024-05-11 https://compoundevidence.com/monographs/bpc-157/evidence/knee-oa/2024-05-11 https://compoundevidence.com/monographs/tb-500/2025-10-13 https://compoundevidence.com/monographs/tb-500/pharmacology/2025-10-13 https://compoundevidence.com/monographs/tb-500/clinical-evidence/2025-10-13 https://compoundevidence.com/monographs/tb-500/safety/2025-10-13 https://compoundevidence.com/monographs/tb-500/regulatory/2025-10-13 https://compoundevidence.com/monographs/tb-500/analytical/2025-10-13 https://compoundevidence.com/monographs/tb-500/supply/2025-10-13 https://compoundevidence.com/monographs/tb-500/references/2025-10-13 https://compoundevidence.com/monographs/tb-500/evidence/tendon-injury/2025-10-13 https://compoundevidence.com/monographs/tb-500/evidence/wound-healing/2025-10-13 https://compoundevidence.com/monographs/tb-500/evidence/cvd/2025-10-13 https://compoundevidence.com/monographs/thymosin-beta-4/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/pharmacology/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/clinical-evidence/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/safety/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/regulatory/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/analytical/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/supply/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/references/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/evidence/wound-healing/2023-12-13 https://compoundevidence.com/monographs/thymosin-beta-4/evidence/cvd/2023-12-13 https://compoundevidence.com/monographs/ghk-cu/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/pharmacology/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/clinical-evidence/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/safety/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/regulatory/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/analytical/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/supply/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/references/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/evidence/wound-healing/2026-01-08 https://compoundevidence.com/monographs/ghk-cu/evidence/longevity/2026-01-08 https://compoundevidence.com/monographs/kpv/2024-03-01 https://compoundevidence.com/monographs/kpv/pharmacology/2024-03-01 https://compoundevidence.com/monographs/kpv/clinical-evidence/2024-03-01 https://compoundevidence.com/monographs/kpv/safety/2024-03-01 https://compoundevidence.com/monographs/kpv/regulatory/2024-03-01 https://compoundevidence.com/monographs/kpv/analytical/2024-03-01 https://compoundevidence.com/monographs/kpv/supply/2024-03-01 https://compoundevidence.com/monographs/kpv/references/2024-03-01 https://compoundevidence.com/monographs/kpv/evidence/ibd/2024-03-01 https://compoundevidence.com/monographs/kpv/evidence/wound-healing/2024-03-01 https://compoundevidence.com/monographs/larazotide/2026-05-07 https://compoundevidence.com/monographs/larazotide/pharmacology/2026-05-07 https://compoundevidence.com/monographs/larazotide/clinical-evidence/2026-05-07 https://compoundevidence.com/monographs/larazotide/safety/2026-05-07 https://compoundevidence.com/monographs/larazotide/regulatory/2026-05-07 https://compoundevidence.com/monographs/larazotide/analytical/2026-05-07 https://compoundevidence.com/monographs/larazotide/supply/2026-05-07 https://compoundevidence.com/monographs/larazotide/references/2026-05-07 https://compoundevidence.com/monographs/larazotide/evidence/ibd/2026-05-07 https://compoundevidence.com/monographs/semax/2026-04-19 https://compoundevidence.com/monographs/semax/pharmacology/2026-04-19 https://compoundevidence.com/monographs/semax/clinical-evidence/2026-04-19 https://compoundevidence.com/monographs/semax/safety/2026-04-19 https://compoundevidence.com/monographs/semax/regulatory/2026-04-19 https://compoundevidence.com/monographs/semax/analytical/2026-04-19 https://compoundevidence.com/monographs/semax/supply/2026-04-19 https://compoundevidence.com/monographs/semax/references/2026-04-19 https://compoundevidence.com/monographs/semax/evidence/cognitive/2026-04-19 https://compoundevidence.com/monographs/semax/evidence/insomnia/2026-04-19 https://compoundevidence.com/monographs/selank/2026-02-09 https://compoundevidence.com/monographs/selank/pharmacology/2026-02-09 https://compoundevidence.com/monographs/selank/clinical-evidence/2026-02-09 https://compoundevidence.com/monographs/selank/safety/2026-02-09 https://compoundevidence.com/monographs/selank/regulatory/2026-02-09 https://compoundevidence.com/monographs/selank/analytical/2026-02-09 https://compoundevidence.com/monographs/selank/supply/2026-02-09 https://compoundevidence.com/monographs/selank/references/2026-02-09 https://compoundevidence.com/monographs/selank/evidence/cognitive/2026-02-09 https://compoundevidence.com/monographs/dsip/2026-05-24 https://compoundevidence.com/monographs/dsip/pharmacology/2026-05-24 https://compoundevidence.com/monographs/dsip/clinical-evidence/2026-05-24 https://compoundevidence.com/monographs/dsip/safety/2026-05-24 https://compoundevidence.com/monographs/dsip/regulatory/2026-05-24 https://compoundevidence.com/monographs/dsip/analytical/2026-05-24 https://compoundevidence.com/monographs/dsip/supply/2026-05-24 https://compoundevidence.com/monographs/dsip/references/2026-05-24 https://compoundevidence.com/monographs/dsip/evidence/insomnia/2026-05-24 https://compoundevidence.com/monographs/dsip/evidence/cognitive/2026-05-24 https://compoundevidence.com/monographs/dsip/evidence/addiction-alcohol/2026-05-24 https://compoundevidence.com/monographs/epithalon/2025-01-26 https://compoundevidence.com/monographs/epithalon/pharmacology/2025-01-26 https://compoundevidence.com/monographs/epithalon/clinical-evidence/2025-01-26 https://compoundevidence.com/monographs/epithalon/safety/2025-01-26 https://compoundevidence.com/monographs/epithalon/regulatory/2025-01-26 https://compoundevidence.com/monographs/epithalon/analytical/2025-01-26 https://compoundevidence.com/monographs/epithalon/supply/2025-01-26 https://compoundevidence.com/monographs/epithalon/references/2025-01-26 https://compoundevidence.com/monographs/epithalon/evidence/longevity/2025-01-26 https://compoundevidence.com/monographs/epithalon/evidence/cognitive/2025-01-26 https://compoundevidence.com/monographs/epithalon/evidence/immune-support/2025-01-26 https://compoundevidence.com/monographs/thymosin-alpha-1/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/pharmacology/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/clinical-evidence/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/safety/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/regulatory/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/analytical/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/supply/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/references/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/evidence/immune-support/2026-01-23 https://compoundevidence.com/monographs/thymosin-alpha-1/evidence/cognitive/2026-01-23 https://compoundevidence.com/monographs/thymalin/2026-07-15 https://compoundevidence.com/monographs/thymalin/pharmacology/2026-07-15 https://compoundevidence.com/monographs/thymalin/clinical-evidence/2026-07-15 https://compoundevidence.com/monographs/thymalin/safety/2026-07-15 https://compoundevidence.com/monographs/thymalin/regulatory/2026-07-15 https://compoundevidence.com/monographs/thymalin/analytical/2026-07-15 https://compoundevidence.com/monographs/thymalin/supply/2026-07-15 https://compoundevidence.com/monographs/thymalin/references/2026-07-15 https://compoundevidence.com/monographs/thymalin/evidence/immune-support/2026-07-15 https://compoundevidence.com/monographs/thymalin/evidence/longevity/2026-07-15 https://compoundevidence.com/monographs/ll-37/2026-04-27 https://compoundevidence.com/monographs/ll-37/pharmacology/2026-04-27 https://compoundevidence.com/monographs/ll-37/clinical-evidence/2026-04-27 https://compoundevidence.com/monographs/ll-37/safety/2026-04-27 https://compoundevidence.com/monographs/ll-37/regulatory/2026-04-27 https://compoundevidence.com/monographs/ll-37/analytical/2026-04-27 https://compoundevidence.com/monographs/ll-37/supply/2026-04-27 https://compoundevidence.com/monographs/ll-37/references/2026-04-27 https://compoundevidence.com/monographs/ll-37/evidence/wound-healing/2026-04-27 https://compoundevidence.com/monographs/ll-37/evidence/immune-support/2026-04-27 https://compoundevidence.com/monographs/mots-c/2025-08-20 https://compoundevidence.com/monographs/mots-c/pharmacology/2025-08-20 https://compoundevidence.com/monographs/mots-c/clinical-evidence/2025-08-20 https://compoundevidence.com/monographs/mots-c/safety/2025-08-20 https://compoundevidence.com/monographs/mots-c/regulatory/2025-08-20 https://compoundevidence.com/monographs/mots-c/analytical/2025-08-20 https://compoundevidence.com/monographs/mots-c/supply/2025-08-20 https://compoundevidence.com/monographs/mots-c/references/2025-08-20 https://compoundevidence.com/monographs/mots-c/evidence/t2dm/2025-08-20 https://compoundevidence.com/monographs/mots-c/evidence/obesity/2025-08-20 https://compoundevidence.com/monographs/mots-c/evidence/longevity/2025-08-20 https://compoundevidence.com/monographs/mots-c/evidence/mitochondrial/2025-08-20 https://compoundevidence.com/monographs/ss-31/2025-04-17 https://compoundevidence.com/monographs/ss-31/pharmacology/2025-04-17 https://compoundevidence.com/monographs/ss-31/clinical-evidence/2025-04-17 https://compoundevidence.com/monographs/ss-31/safety/2025-04-17 https://compoundevidence.com/monographs/ss-31/regulatory/2025-04-17 https://compoundevidence.com/monographs/ss-31/analytical/2025-04-17 https://compoundevidence.com/monographs/ss-31/supply/2025-04-17 https://compoundevidence.com/monographs/ss-31/references/2025-04-17 https://compoundevidence.com/monographs/ss-31/evidence/mitochondrial/2025-04-17 https://compoundevidence.com/monographs/ss-31/evidence/hfpef/2025-04-17 https://compoundevidence.com/monographs/ss-31/evidence/cvd/2025-04-17 https://compoundevidence.com/monographs/nad-plus/2026-08-23 https://compoundevidence.com/monographs/nad-plus/pharmacology/2026-08-23 https://compoundevidence.com/monographs/nad-plus/clinical-evidence/2026-08-23 https://compoundevidence.com/monographs/nad-plus/safety/2026-08-23 https://compoundevidence.com/monographs/nad-plus/regulatory/2026-08-23 https://compoundevidence.com/monographs/nad-plus/analytical/2026-08-23 https://compoundevidence.com/monographs/nad-plus/supply/2026-08-23 https://compoundevidence.com/monographs/nad-plus/references/2026-08-23 https://compoundevidence.com/monographs/nad-plus/evidence/longevity/2026-08-23 https://compoundevidence.com/monographs/nad-plus/evidence/addiction-alcohol/2026-08-23 https://compoundevidence.com/monographs/nad-plus/evidence/cognitive/2026-08-23 https://compoundevidence.com/monographs/nad-plus/evidence/mitochondrial/2026-08-23 https://compoundevidence.com/monographs/glutathione/2026-05-06 https://compoundevidence.com/monographs/glutathione/pharmacology/2026-05-06 https://compoundevidence.com/monographs/glutathione/clinical-evidence/2026-05-06 https://compoundevidence.com/monographs/glutathione/safety/2026-05-06 https://compoundevidence.com/monographs/glutathione/regulatory/2026-05-06 https://compoundevidence.com/monographs/glutathione/analytical/2026-05-06 https://compoundevidence.com/monographs/glutathione/supply/2026-05-06 https://compoundevidence.com/monographs/glutathione/references/2026-05-06 https://compoundevidence.com/monographs/glutathione/evidence/cognitive/2026-05-06 https://compoundevidence.com/monographs/glutathione/evidence/immune-support/2026-05-06 https://compoundevidence.com/monographs/glutathione/evidence/longevity/2026-05-06 https://compoundevidence.com/monographs/5-amino-1mq/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/pharmacology/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/clinical-evidence/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/safety/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/regulatory/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/analytical/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/supply/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/references/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/evidence/obesity/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/evidence/t2dm/2025-12-07 https://compoundevidence.com/monographs/5-amino-1mq/evidence/longevity/2025-12-07 https://compoundevidence.com/monographs/pt-141/2024-08-15 https://compoundevidence.com/monographs/pt-141/pharmacology/2024-08-15 https://compoundevidence.com/monographs/pt-141/clinical-evidence/2024-08-15 https://compoundevidence.com/monographs/pt-141/safety/2024-08-15 https://compoundevidence.com/monographs/pt-141/regulatory/2024-08-15 https://compoundevidence.com/monographs/pt-141/analytical/2024-08-15 https://compoundevidence.com/monographs/pt-141/supply/2024-08-15 https://compoundevidence.com/monographs/pt-141/references/2024-08-15 https://compoundevidence.com/monographs/pt-141/evidence/sexual-dysfunction/2024-08-15 https://compoundevidence.com/monographs/melanotan-ii/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/pharmacology/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/clinical-evidence/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/safety/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/regulatory/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/analytical/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/supply/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/references/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/evidence/sexual-dysfunction/2024-12-02 https://compoundevidence.com/monographs/melanotan-ii/evidence/obesity/2024-12-02 https://compoundevidence.com/monographs/kisspeptin-10/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/pharmacology/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/clinical-evidence/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/safety/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/regulatory/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/analytical/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/supply/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/references/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/evidence/pcos/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/evidence/sexual-dysfunction/2025-06-11 https://compoundevidence.com/monographs/kisspeptin-10/evidence/ghd/2025-06-11 https://compoundevidence.com/monographs/gonadorelin/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/pharmacology/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/clinical-evidence/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/safety/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/regulatory/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/analytical/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/supply/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/references/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/evidence/ghd/2024-01-18 https://compoundevidence.com/monographs/gonadorelin/evidence/pcos/2024-01-18